Adalimumab, a fully human anti–tumor necrosis factor α monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: The ARMADA trial

Name: Work Video:
Duration: 3 min 30 s
Michael E. Weinblatt; Edward Keystone; Daniel E. Furst; Larry W. Moreland; Michael H. Weisman; C. Birbara; Leah A. Teoh; Steven Fischkoff; Elliot Chartash
{'id': 'https://openalex.org/W1979364075', 'doi': 'https://doi.org/10.1002/art.10697', 'title': 'Adalimumab, a fully human anti–tumor necrosis factor α monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: The ARMADA trial', 'display_name': 'Adalimumab, a fully human anti–tumor necrosis factor α monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: The ARMADA trial', 'publication_year': 2003, 'publication_date': '2003-01-01', 'ids': {'openalex': 'https://openalex.org/W1979364075', 'doi': 'https://doi.org/10.1002/art.10697', 'mag': '1979364075', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/12528101'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1002/art.10697', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S132787887', 'display_name': 'Arthritis & Rheumatism', 'issn_l': '0004-3591', 'issn': ['0004-3591', '1529-0131'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320595', 'host_organization_name': 'Wiley', 'host_organization_lineage': ['https://openalex.org/P4310320595'], 'host_organization_lineage_names': ['Wiley'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5047117557', 'display_name': 'Michael E. Weinblatt', 'orcid': 'https://orcid.org/0000-0001-5215-5512'}, 'institutions': [{'id': 'https://openalex.org/I1283280774', 'display_name': "Brigham and Women's Hospital", 'ror': 'https://ror.org/04b6nzv94', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1283280774', 'https://openalex.org/I48633490']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Michael E. Weinblatt', 'raw_affiliation_strings': ["Rheumatology and Immunology, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA."], 'affiliations': [{'raw_affiliation_string': "Rheumatology and Immunology, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.", 'institution_ids': ['https://openalex.org/I1283280774']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5080646462', 'display_name': 'Edward Keystone', 'orcid': 'https://orcid.org/0000-0001-6606-0071'}, 'institutions': [{'id': 'https://openalex.org/I1291836623', 'display_name': 'Mount Sinai Hospital', 'ror': 'https://ror.org/05deks119', 'country_code': 'CA', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1291836623', 'https://openalex.org/I4210130843']}], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'Edward C. Keystone', 'raw_affiliation_strings': ['Mount Sinai Hospital , Toronto , Ontario , Canada'], 'affiliations': [{'raw_affiliation_string': 'Mount Sinai Hospital , Toronto , Ontario , Canada', 'institution_ids': ['https://openalex.org/I1291836623']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5059206584', 'display_name': 'Daniel E. Furst', 'orcid': 'https://orcid.org/0000-0001-7857-2373'}, 'institutions': [{'id': 'https://openalex.org/I161318765', 'display_name': 'University of California, Los Angeles', 'ror': 'https://ror.org/046rm7j60', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I161318765']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Daniel E. Furst', 'raw_affiliation_strings': ['University of California–Los Angeles'], 'affiliations': [{'raw_affiliation_string': 'University of California–Los Angeles', 'institution_ids': ['https://openalex.org/I161318765']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5066780563', 'display_name': 'Larry W. Moreland', 'orcid': 'https://orcid.org/0000-0003-4483-0359'}, 'institutions': [{'id': 'https://openalex.org/I32389192', 'display_name': 'University of Alabama at Birmingham', 'ror': 'https://ror.org/008s83205', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I32389192']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Larry W. Moreland', 'raw_affiliation_strings': ['The University of Alabama at Birmingham,'], 'affiliations': [{'raw_affiliation_string': 'The University of Alabama at Birmingham,', 'institution_ids': ['https://openalex.org/I32389192']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5030335777', 'display_name': 'Michael H. Weisman', 'orcid': 'https://orcid.org/0000-0001-5568-388X'}, 'institutions': [{'id': 'https://openalex.org/I1282927834', 'display_name': 'Cedars-Sinai Medical Center', 'ror': 'https://ror.org/02pammg90', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1282927834']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Michael H. Weisman', 'raw_affiliation_strings': ['Cedars-Sinai Medical Center; Los Angeles, California'], 'affiliations': [{'raw_affiliation_string': 'Cedars-Sinai Medical Center; Los Angeles, California', 'institution_ids': ['https://openalex.org/I1282927834']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5112035604', 'display_name': 'C. Birbara', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I24603500', 'display_name': 'University of Massachusetts Amherst', 'ror': 'https://ror.org/0072zz521', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I24603500']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Charles A. Birbara', 'raw_affiliation_strings': ['University of Massachusetts City Campus, Worcester'], 'affiliations': [{'raw_affiliation_string': 'University of Massachusetts City Campus, Worcester', 'institution_ids': ['https://openalex.org/I24603500']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5088360064', 'display_name': 'Leah A. Teoh', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210125531', 'display_name': 'Reckitt Benckiser (United States)', 'ror': 'https://ror.org/030893n97', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210115825', 'https://openalex.org/I4210125531']}, {'id': 'https://openalex.org/I4210088555', 'display_name': 'Abbott (United States)', 'ror': 'https://ror.org/0052svj16', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210088555']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Leah A. Teoh', 'raw_affiliation_strings': ['Abbott Laboratories, Parsippany, New Jersey'], 'affiliations': [{'raw_affiliation_string': 'Abbott Laboratories, Parsippany, New Jersey', 'institution_ids': ['https://openalex.org/I4210125531', 'https://openalex.org/I4210088555']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5027350585', 'display_name': 'Steven Fischkoff', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210125531', 'display_name': 'Reckitt Benckiser (United States)', 'ror': 'https://ror.org/030893n97', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210115825', 'https://openalex.org/I4210125531']}, {'id': 'https://openalex.org/I4210088555', 'display_name': 'Abbott (United States)', 'ror': 'https://ror.org/0052svj16', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210088555']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Steven A. Fischkoff', 'raw_affiliation_strings': ['Abbott Laboratories, Parsippany, New Jersey'], 'affiliations': [{'raw_affiliation_string': 'Abbott Laboratories, Parsippany, New Jersey', 'institution_ids': ['https://openalex.org/I4210125531', 'https://openalex.org/I4210088555']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5009369964', 'display_name': 'Elliot Chartash', 'orcid': 'https://orcid.org/0000-0002-4836-2372'}, 'institutions': [{'id': 'https://openalex.org/I4210125531', 'display_name': 'Reckitt Benckiser (United States)', 'ror': 'https://ror.org/030893n97', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210115825', 'https://openalex.org/I4210125531']}, {'id': 'https://openalex.org/I4210088555', 'display_name': 'Abbott (United States)', 'ror': 'https://ror.org/0052svj16', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210088555']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Elliot K. Chartash', 'raw_affiliation_strings': ['Abbott Laboratories, Parsippany, New Jersey'], 'affiliations': [{'raw_affiliation_string': 'Abbott Laboratories, Parsippany, New Jersey', 'institution_ids': ['https://openalex.org/I4210125531', 'https://openalex.org/I4210088555']}]}], 'institution_assertions': [], 'countries_distinct_count': 2, 'institutions_distinct_count': 8, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 82.444, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 1750, 'citation_normalized_percentile': {'value': 0.999831, 'is_in_top_1_percent': True, 'is_in_top_10_percent': True}, 'cited_by_percentile_year': {'min': 99, 'max': 100}, 'biblio': {'volume': '48', 'issue': '1', 'first_page': '35', 'last_page': '45'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10200', 'display_name': 'Rheumatoid Arthritis Research and Therapies', 'score': 0.9998, 'subfield': {'id': 'https://openalex.org/subfields/2745', 'display_name': 'Rheumatology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10200', 'display_name': 'Rheumatoid Arthritis Research and Therapies', 'score': 0.9998, 'subfield': {'id': 'https://openalex.org/subfields/2745', 'display_name': 'Rheumatology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11616', 'display_name': 'Autoimmune and Inflammatory Disorders Research', 'score': 0.9991, 'subfield': {'id': 'https://openalex.org/subfields/2720', 'display_name': 'Hematology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11157', 'display_name': 'Chronic Lymphocytic Leukemia Research', 'score': 0.9943, 'subfield': {'id': 'https://openalex.org/subfields/2716', 'display_name': 'Genetics'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/concomitant', 'display_name': 'Concomitant', 'score': 0.63762397}], 'concepts': [{'id': 'https://openalex.org/C2780132546', 'wikidata': 'https://www.wikidata.org/wiki/Q348260', 'display_name': 'Adalimumab', 'level': 3, 'score': 0.975608}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.8843494}, {'id': 'https://openalex.org/C2777575956', 'wikidata': 'https://www.wikidata.org/wiki/Q187255', 'display_name': 'Rheumatoid arthritis', 'level': 2, 'score': 0.85167325}, {'id': 'https://openalex.org/C27081682', 'wikidata': 'https://www.wikidata.org/wiki/Q269829', 'display_name': 'Placebo', 'level': 3, 'score': 0.71991235}, {'id': 'https://openalex.org/C2781059491', 'wikidata': 'https://www.wikidata.org/wiki/Q422232', 'display_name': 'Methotrexate', 'level': 2, 'score': 0.71268624}, {'id': 'https://openalex.org/C2779384505', 'wikidata': 'https://www.wikidata.org/wiki/Q17007513', 'display_name': 'Concomitant', 'level': 2, 'score': 0.63762397}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.6374814}, {'id': 'https://openalex.org/C198451711', 'wikidata': 'https://www.wikidata.org/wiki/Q327657', 'display_name': 'Rheumatology', 'level': 2, 'score': 0.57523453}, {'id': 'https://openalex.org/C90924648', 'wikidata': 'https://www.wikidata.org/wiki/Q120569', 'display_name': 'Gastroenterology', 'level': 1, 'score': 0.46416572}, {'id': 'https://openalex.org/C17991360', 'wikidata': 'https://www.wikidata.org/wiki/Q21173843', 'display_name': 'Tumor necrosis factor alpha', 'level': 2, 'score': 0.46282986}, {'id': 'https://openalex.org/C2777077863', 'wikidata': 'https://www.wikidata.org/wiki/Q170990', 'display_name': 'Arthritis', 'level': 2, 'score': 0.45246908}, {'id': 'https://openalex.org/C142724271', 'wikidata': 'https://www.wikidata.org/wiki/Q7208', 'display_name': 'Pathology', 'level': 1, 'score': 0.08882436}, {'id': 'https://openalex.org/C204787440', 'wikidata': 'https://www.wikidata.org/wiki/Q188504', 'display_name': 'Alternative medicine', 'level': 2, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D000911', 'descriptor_name': 'Antibodies, Monoclonal', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': True}, {'descriptor_ui': 'D018501', 'descriptor_name': 'Antirheumatic Agents', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': True}, {'descriptor_ui': 'D001172', 'descriptor_name': 'Arthritis, Rheumatoid', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D008727', 'descriptor_name': 'Methotrexate', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': True}, {'descriptor_ui': 'D014409', 'descriptor_name': 'Tumor Necrosis Factor-alpha', 'qualifier_ui': 'Q000037', 'qualifier_name': 'antagonists & inhibitors', 'is_major_topic': True}, {'descriptor_ui': 'D000068879', 'descriptor_name': 'Adalimumab', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000328', 'descriptor_name': 'Adult', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000368', 'descriptor_name': 'Aged', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000911', 'descriptor_name': 'Antibodies, Monoclonal', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D000911', 'descriptor_name': 'Antibodies, Monoclonal', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D061067', 'descriptor_name': 'Antibodies, Monoclonal, Humanized', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D018501', 'descriptor_name': 'Antirheumatic Agents', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D018501', 'descriptor_name': 'Antirheumatic Agents', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D001172', 'descriptor_name': 'Arthritis, Rheumatoid', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D017364', 'descriptor_name': 'Collagenases', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D017364', 'descriptor_name': 'Collagenases', 'qualifier_ui': 'Q000097', 'qualifier_name': 'blood', 'is_major_topic': False}, {'descriptor_ui': 'D003131', 'descriptor_name': 'Combined Modality Therapy', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004792', 'descriptor_name': 'Enzyme Precursors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004792', 'descriptor_name': 'Enzyme Precursors', 'qualifier_ui': 'Q000097', 'qualifier_name': 'blood', 'is_major_topic': False}, {'descriptor_ui': 'D005221', 'descriptor_name': 'Fatigue', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005221', 'descriptor_name': 'Fatigue', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': False}, {'descriptor_ui': 'D005260', 'descriptor_name': 'Female', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008297', 'descriptor_name': 'Male', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D020781', 'descriptor_name': 'Matrix Metalloproteinase 1', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008666', 'descriptor_name': 'Metalloendopeptidases', 'qualifier_ui': 'Q000097', 'qualifier_name': 'blood', 'is_major_topic': False}, {'descriptor_ui': 'D008666', 'descriptor_name': 'Metalloendopeptidases', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008727', 'descriptor_name': 'Methotrexate', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D008727', 'descriptor_name': 'Methotrexate', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008875', 'descriptor_name': 'Middle Aged', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D012720', 'descriptor_name': 'Severity of Illness Index', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D016896', 'descriptor_name': 'Treatment Outcome', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014409', 'descriptor_name': 'Tumor Necrosis Factor-alpha', 'qualifier_ui': 'Q000276', 'qualifier_name': 'immunology', 'is_major_topic': False}, {'descriptor_ui': 'D014409', 'descriptor_name': 'Tumor Necrosis Factor-alpha', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1002/art.10697', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S132787887', 'display_name': 'Arthritis & Rheumatism', 'issn_l': '0004-3591', 'issn': ['0004-3591', '1529-0131'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320595', 'host_organization_name': 'Wiley', 'host_organization_lineage': ['https://openalex.org/P4310320595'], 'host_organization_lineage_names': ['Wiley'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/12528101', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'score': 0.83, 'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 28, 'referenced_works': ['https://openalex.org/W134148254', 'https://openalex.org/W1744000831', 'https://openalex.org/W1967850532', 'https://openalex.org/W1988108320', 'https://openalex.org/W2033299724', 'https://openalex.org/W2037377025', 'https://openalex.org/W2041499523', 'https://openalex.org/W2065419533', 'https://openalex.org/W2097315308', 'https://openalex.org/W2100285949', 'https://openalex.org/W2100936707', 'https://openalex.org/W2131658103', 'https://openalex.org/W2142273705', 'https://openalex.org/W2142500530', 'https://openalex.org/W2145481747', 'https://openalex.org/W2152348310', 'https://openalex.org/W2159106700', 'https://openalex.org/W2328587823', 'https://openalex.org/W2331320446', 'https://openalex.org/W2336588424', 'https://openalex.org/W2407404951', 'https://openalex.org/W2410608238', 'https://openalex.org/W2416586448', 'https://openalex.org/W2471279106', 'https://openalex.org/W2600516270', 'https://openalex.org/W334564628', 'https://openalex.org/W4292806894', 'https://openalex.org/W45832520'], 'related_works': ['https://openalex.org/W3158974035', 'https://openalex.org/W3097370318', 'https://openalex.org/W3081648646', 'https://openalex.org/W2901883939', 'https://openalex.org/W2563362192', 'https://openalex.org/W2560260758', 'https://openalex.org/W2405634423', 'https://openalex.org/W2316822442', 'https://openalex.org/W2090686119', 'https://openalex.org/W1578809130'], 'abstract_inverted_index': {'Abstract': [0], 'Objective': [1], 'To': [2], 'evaluate': [3], 'the': [4, 86, 116, 132, 146, 217, 228], 'efficacy': [5, 82], 'and': [6, 119, 127, 149, 155, 173, 180, 192, 209, 237, 245, 284], 'safety': [7], 'of': [8, 55, 78, 89, 113, 183, 220, 242, 254, 259], 'adalimumab': [9, 56, 121, 151, 184, 255], '(D2E7),': [10], 'a': [11, 38, 109, 257], 'fully': [12], 'human': [13], 'monoclonal': [14], 'tumor': [15], 'necrosis': [16], 'factor': [17], 'α': [18], 'antibody,': [19], 'in': [20, 25, 115, 131, 276, 287], 'combination': [21], 'with': [22, 27, 34, 46, 145, 163, 187, 202, 216, 278, 294], 'methotrexate': [23], '(MTX)': [24], 'patients': [26, 45, 114, 222, 244, 247, 277], 'active': [28, 47, 279], 'rheumatoid': [29], 'arthritis': [30], '(RA)': [31], 'despite': [32], 'treatment': [33], 'MTX.': [35, 79], 'Methods': [36], 'In': [37], '24‐week,': [39], 'randomized,': [40], 'double‐blind,': [41], 'placebo‐controlled': [42], 'study,': [43], '271': [44], 'RA': [48, 280], 'were': [49, 158, 185, 214], 'randomly': [50], 'assigned': [51], 'to': [52, 72, 272], 'receive': [53], 'injections': [54], '(20': [57], 'mg,': [58, 60, 261, 263], '40': [59, 262], 'or': [61, 65, 264], '80': [62, 265], 'mg': [63, 266], 'subcutaneously)': [64], 'placebo': [66, 133, 164, 203], 'every': [67, 269], 'other': [68, 270], 'week': [69, 104, 271], 'while': [70], 'continuing': [71], 'take': [73], 'their': [74], 'long‐term': [75, 273], 'stable': [76], 'dosage': [77, 258], 'The': [80, 178, 252], 'primary': [81], 'end': [83], 'point': [84], 'was': [85, 106, 196, 235], 'American': [87], 'College': [88], 'Rheumatology': [90], 'criteria': [91], 'for': [92], '20%': [93], 'improvement': [94, 286], '(ACR20)': [95], 'at': [96, 103, 227, 256], '24': [97, 105, 291], 'weeks.': [98], 'Results': [99], 'An': [100], 'ACR20': [101, 225], 'response': [102, 143, 190, 226], 'achieved': [107], 'by': [108], 'significantly': [110, 159, 198], 'greater': [111, 160, 199], 'proportion': [112, 219], '20‐mg,': [117, 147], '40‐mg,': [118, 148], '80‐mg': [120, 150, 181], 'plus': [122, 134, 296], 'MTX': [123, 135, 274, 295], 'groups': [124], '(47.8%,': [125], '67.2%,': [126], '65.8%,': [128], 'respectively)': [129, 157, 194], 'than': [130, 161, 200], 'group': [136], '(14.5%)': [137], '(': [138, 166, 205], 'P': [139, 167, 170, 174, 206, 210], '&lt;': [140, 171, 175, 207], '0.001).': [141], 'ACR50': [142], 'rates': [144], 'dosages': [152], '(31.9%,': [153], '55.2%,': [154], '42.5%,': [156], 'that': [162, 195, 201], '(8.1%)': [165], '=': [168, 211], '0.003,': [169], '0.001,': [172, 176], 'respectively).': [177], '40‐mg': [179], 'doses': [182], 'associated': [186], 'an': [188, 224], 'ACR70': [189], '(26.9%': [191], '19.2%,': [193], 'statistically': [197], '(4.8%)': [204], '0.001': [208], '0.020).': [212], 'Responses': [213], 'rapid,': [215, 283], 'greatest': [218], 'adalimumab‐treated': [221, 243], 'achieving': [223], 'first': [229], 'scheduled': [230], 'visit': [231], '(week': [232], '1).': [233], 'Adalimumab': [234], 'safe': [236], 'well': [238], 'tolerated;': [239], 'comparable': [240], 'numbers': [241], 'placebo‐treated': [246], 'reported': [248], 'adverse': [249], 'events.': [250], 'Conclusion': [251], 'addition': [253], '20': [260], 'administered': [267], 'subcutaneously': [268], 'therapy': [275], 'provided': [281], 'significant,': [282], 'sustained': [285], 'disease': [288], 'activity': [289], 'over': [290], 'weeks': [292], 'compared': [293], 'placebo.': [297]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W1979364075', 'counts_by_year': [{'year': 2024, 'cited_by_count': 22}, {'year': 2023, 'cited_by_count': 31}, {'year': 2022, 'cited_by_count': 33}, {'year': 2021, 'cited_by_count': 37}, {'year': 2020, 'cited_by_count': 48}, {'year': 2019, 'cited_by_count': 58}, {'year': 2018, 'cited_by_count': 48}, {'year': 2017, 'cited_by_count': 43}, {'year': 2016, 'cited_by_count': 77}, {'year': 2015, 'cited_by_count': 70}, {'year': 2014, 'cited_by_count': 80}, {'year': 2013, 'cited_by_count': 103}, {'year': 2012, 'cited_by_count': 82}], 'updated_date': '2024-12-14T07:12:31.424687', 'created_date': '2016-06-24'}
Publication Information

Basic Information

Access and Citation

AI Researcher Chatbot

Primary Location

Authors

Topics

Keywords

Related Works
